Gregory Leiter APM 3 years ago #1Good interview with CEO. Phase 2 trials in 2023 and are commercializing menapause supplement likely in US and Europe in 2023 which is huge market. Currently selling it Asia I believe. So company has short term revenue generating products as well as pipeline products.